These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23385800)
21. Initial exploration of oral pazopanib in healthy participants and patients with age-related macular degeneration. McLaughlin MM; Paglione MG; Slakter J; Tolentino M; Ye L; Xu CF; Suttle AB; Kim RY JAMA Ophthalmol; 2013 Dec; 131(12):1595-601. PubMed ID: 24113783 [TBL] [Abstract][Full Text] [Related]
22. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases. Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration. Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001 [TBL] [Abstract][Full Text] [Related]
24. Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration. Meredith EL; Mainolfi N; Poor S; Qiu Y; Miranda K; Powers J; Liu D; Ma F; Solovay C; Rao C; Johnson L; Ji N; Artman G; Hardegger L; Hanks S; Shen S; Woolfenden A; Fassbender E; Sivak JM; Zhang Y; Long D; Cepeda R; Liu F; Hosagrahara VP; Lee W; Tarsa P; Anderson K; Elliott J; Jaffee B J Med Chem; 2015 Dec; 58(23):9273-86. PubMed ID: 26568411 [TBL] [Abstract][Full Text] [Related]
25. Effect of eye pigmentation on transscleral drug delivery. Cheruvu NP; Amrite AC; Kompella UB Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):333-41. PubMed ID: 18172110 [TBL] [Abstract][Full Text] [Related]
26. Suppression of experimental choroidal neovascularization by curcumin in mice. Xie P; Zhang W; Yuan S; Chen Z; Yang Q; Yuan D; Wang F; Liu Q PLoS One; 2012; 7(12):e53329. PubMed ID: 23285282 [TBL] [Abstract][Full Text] [Related]
27. Potential of subconjunctival aflibercept in treating choroidal neovascularization. Nirmal J; Barathi VA; Dickescheid A; Wey YS; Nirmal S; Raja MM; Venkatraman S; Agrawal R Exp Eye Res; 2020 Oct; 199():108187. PubMed ID: 32795527 [TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat. Kamizuru H; Kimura H; Yasukawa T; Tabata Y; Honda Y; Ogura Y Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2664-72. PubMed ID: 11581214 [TBL] [Abstract][Full Text] [Related]
29. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization. Seo S; Suh W Mol Vis; 2017; 23():823-831. PubMed ID: 29225458 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor. Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591 [TBL] [Abstract][Full Text] [Related]
31. A Pharmacodynamic Analysis of Choroidal Neovascularization in a Porcine Model Using Three Targeted Drugs. Tran J; Craven C; Wabner K; Schmit J; Matter B; Kompella U; Grossniklaus HE; Olsen TW Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3732-3740. PubMed ID: 28738417 [TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptides. Recalde S; Zarranz-Ventura J; Fernández-Robredo P; García-Gómez PJ; Salinas-Alamán A; Borrás-Cuesta F; Dotor J; García-Layana A Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7090-7. PubMed ID: 21810978 [TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic effects of topically administered multiple kinase inhibitor, motesanib (AMG 706), on experimental choroidal neovascularization in mice. Rho CR; Kang S; Park KC; Yang KJ; Choi H; Cho WK J Ocul Pharmacol Ther; 2015 Feb; 31(1):25-31. PubMed ID: 25255037 [TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization. Amparo F; Sadrai Z; Jin Y; Alfonso-Bartolozzi B; Wang H; Shikari H; Ciolino JB; Chodosh J; Jurkunas U; Schaumberg DA; Dana R Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):537-44. PubMed ID: 23233252 [TBL] [Abstract][Full Text] [Related]